Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel and Cisplatin vs CEF as Adjuvant Chemotherapy in Breast Cancer
NCT02879513Phase 3Unknown
- Sponsor
- Renji Hospital
- Start
- Jan 2014
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of paclitaxel, cisplatin in breast cancer, sponsored by Renji Hospital. Status: unknown.
02
Drugs
paclitaxelcisplatin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02879513.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02879513.